Jm. Itier et al., HUMAN INSULIN GENE-EXPRESSION IN TRANSGENIC MICE - MUTATIONAL ANALYSIS OF THE REGULATORY REGION, Differentiation, 60(5), 1996, pp. 309-316
A mini-human insulin gene and four derivatives mutated at several regi
ons potentially involved in the regulation of gene expression were use
d to generate transgenic mouse lines. The effect of these mutations on
the efficiency of gene expression and cell specificity was studied us
ing three approaches: (1) Northern blot analysis using total RNA from
pancreas and other organs, (2) radioimmunoassay to detect the human C-
peptide in urine samples, and (3) immunocytochemistry of pancreas sect
ions to examine whether expression of the transgene was still specific
ally expressed in beta-cells. Mutation of the cis-acting elements loca
ted between -238 and -206 (GCII and CTII motifs) resulted in a strong
decrease of gene expression in the pancreas of transgenic mice, but it
did not lead to complete extinction of the transgene expression. This
region alone (-255/-202), when linked to the minimal Herpes simplex v
irus thymidine kinase gene (tk) promoter, failed to activate chloramph
enicol acetyltransferase (CAT) gene expression in transfected insulino
ma cells, while it was activated by the equivalent region of the rat i
nsulin I gene. On the contrary, mutation of the DNA motifs located bet
ween -109 and -75 (GCI and CTI) or between -323 and 297 (CTIII) did no
t significantly affect the level of the human insulin gene expression
in transgenic mice. Replacement of the insulin promoter (-58/+1) by th
e tk promoter did not alter its level of expression in transgenic mice
. In all instances, expression of the different transgenes remained lo
calized in the islet beta-cells. Altogether, these results indicate th
at the GCII-CTII motif is an important regulatory element for efficien
t expression of the human insulin gene in vivo, although it alone does
not allow gene expression as it would require the association of othe
r elements.